Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Fuji

Showing results (91-100 of 191) with videos related to

Pageof 20
Sort By:
Bone Marrow Transplantation|February 21, 2018
The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemiaKiyosumi Ochi, Shigeo Fuji, Kuniko Takano, et al.
International Journal of Laboratory Hematology|June 15, 2022
Discordance in the morphologic diagnosis of lymphocytes in HTLV-1-infected individualsShigeo Fuji, Masakazu Muta, Eiichiro Ikeda, et al.
Bone Marrow Transplantation|March 11, 2018
Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphomaYoshitaka Inoue, Shigeo Fuji, Ryuji Tanosaki, et al.
International Journal of Hematology|October 5, 2013
Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 casesShigeo Fuji, Niina Ueno, Nobuhiro Hiramoto, et al.
Bone Marrow Transplantation|January 22, 2019
VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysisShigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese PatientsReiko Ito, Yoshihiro Inamoto, Yoshitaka Inoue, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|September 23, 2016
Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016Anca Bojan, Ioana Berindan-Neagoe, S Ciurea, et al.
Transplantation and Cellular Therapy|May 4, 2026
Valemetostat is efficacious against recurrent adult T-cell leukemia/lymphoma skin lesions and cutaneous GVHDYoshiki Matsuoka, Shigeo Fuji, Mako Hosoya, et al.
International Journal of Hematology-Oncology and Stem Cell Research|April 28, 2020
Different Immune Reconstitution between Cord Blood and Unrelated Bone Marrow Transplantation with Relation to Chronic Graft-versus-Host DiseaseHitoshi Yoshida, Midori Koike, Yuma Tada, et al.
American Journal of Hematology|November 10, 2009
Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantationSaiko Kurosawa, Takahiro Fukuda, Kinuko Tajima, et al.
Pageof 20

Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
Bone Marrow Transplantation|February 21, 2018
The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemiaKiyosumi Ochi, Shigeo Fuji, Kuniko Takano, et al.
International Journal of Laboratory Hematology|June 15, 2022
Discordance in the morphologic diagnosis of lymphocytes in HTLV-1-infected individualsShigeo Fuji, Masakazu Muta, Eiichiro Ikeda, et al.
Bone Marrow Transplantation|March 11, 2018
Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphomaYoshitaka Inoue, Shigeo Fuji, Ryuji Tanosaki, et al.
International Journal of Hematology|October 5, 2013
Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 casesShigeo Fuji, Niina Ueno, Nobuhiro Hiramoto, et al.
Bone Marrow Transplantation|January 22, 2019
VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysisShigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese PatientsReiko Ito, Yoshihiro Inamoto, Yoshitaka Inoue, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|September 23, 2016
Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016Anca Bojan, Ioana Berindan-Neagoe, S Ciurea, et al.
Transplantation and Cellular Therapy|May 4, 2026
Valemetostat is efficacious against recurrent adult T-cell leukemia/lymphoma skin lesions and cutaneous GVHDYoshiki Matsuoka, Shigeo Fuji, Mako Hosoya, et al.
International Journal of Hematology-Oncology and Stem Cell Research|April 28, 2020
Different Immune Reconstitution between Cord Blood and Unrelated Bone Marrow Transplantation with Relation to Chronic Graft-versus-Host DiseaseHitoshi Yoshida, Midori Koike, Yuma Tada, et al.
American Journal of Hematology|November 10, 2009
Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantationSaiko Kurosawa, Takahiro Fukuda, Kinuko Tajima, et al.
Pageof 20